3.3. Increased BAX Plasmid Content in the ADi-100 1:2 Formulation Resulted in Greater Efficacy in a Later Stage of Autoimmune Diabetes (i.e., Highly Hyperglycemia). Here, BAX is linked to Hyperglycemia.